ChatenoudL., HerbelinA., BeaurainG., Descamps LatschaB.Immune deficiency of the uremic patient.Kidney Int1986; 29: 259–74.
2.
LewisS., HolmesC.Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Part I.Perit Dial Int1991; 11: 14–21.
3.
LouisF., RuedinP., FreiD., JeannetM., FavreH.Importance of the role of the blood transfusions in delayed hypersensitivity among end-stage renal disease patients.Proc EDTA-ERA1985; 22: 937.
4.
LewisS., HolmesC.Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Part II. Humoral defenses.Perit Dial Int1991; 11: 112–17.
5.
KurzP., KöhlerH., MeuerS., HütterothT., Meyer zum BüschenfeldeK.H.Impaired cellular immune responses in chronic renal failure; evidence for a T-cell defect.Kidney Int1986; 29: 1209–14.
6.
RaskovaJ., GhobrialI., CzerwinskiD.K., SheaS.M., EisingerR.P., RaskaK.B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.Arch Intern Med1987; 147: 89–93.
7.
DegiannisD., MowatA.M., GallowayE.In vitro analysis of B lymphocyte function in uraemia.ClinExp Immunol1987; 70: 463–70.
8.
DaviesS.J.Peritoneal lymphocyte populations in CAPD patients.Contrib Nephrol1990; 85: 16–23.
9.
ZublerR.H., Werner-FavreC., WenL., SekitaK., StraubC.Theoretical and practical aspects of B-cell activation: murine and human systemsImmunol Rev1987; 99: 281.
HolmesC.J., LewisS.L., KubeyW.Y., van EppsD.E.Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis.Am J Kidney Dis1990; 15: 258–64.
12.
TucciA., JamesH., ChicheporticheR., BonnefoyJ-Y, ZublerR.H.Effects of eleven cytokines, and of IL-l and TNF inhibitors, in a human B cell assay.J Immunol1992; 148: 2778–84.
13.
DaviesS.J., SuassunaJ., OggC.S., CameronJ.S.Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.Kidney Int1989; 36: 661–8.
14.
WieslanderA.P., NordinM.K., KjellstrandP.T.T., BobergU.C.Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.Kidney Int1991; 40: 77–9.
15.
BeaurainG., NaretC., MarconL.In vivo T cell preactivation in chronic uremic hemodialyzed and nonhemodialyzed patients.Kidney Int1989; 36: 636–44.
16.
HuangY.P., PerrinL.H., MiescherP.A., ZublerR.H.Correlation of T and B cell activities in vitro and serum IL21evels in systemic lupus erythematosus.J Immunol1988; 141: 827–33.
